NEWS, PRESS & EVENTS

NEWS & EVENTS

The 3rd Annual Translational Microbiome Conference

Date : 11-13 April 2017 Location : Boston (USA) View the link.. Read More →

DDW 2017 Digestive Disease Week

Date : 6-9 May 2017 Location : Chicago (USA) View the link.. Read More →

BioEquity Europe 2017

Date : 22-23 May 2017 Location : Paris (France) View the link.. Read More →

ASCO Annual Meeting

Date : 2-6 June 2017 Location : Chicago (USA) View the link.. Read More →

2017 BIO International Conference

Date : 19-22 June 2017 Location : San Diego (USA) View the link.. Read More →

Pierre Belichard interviewed by MedNous in April 2015 issue

Paris, France – 16 April 2015 Microbiome sets off a rush among developers Pierre Belichard, CEO of Enterome, interviewed by MedNous in April 2015 issue... Read More →

Oral Presentation and Poster at the IHMC congress in Luxembourg

Paris, France – 19 March 2015 Enterome will be present at the International Human Microbiome Congress in Luxembourg, 31 March-2 April 2015. An Oral Presentation.. Read More →

ICTRHN 3rd International Congress of Translational Research in Human Nutrition

Date : 26-27 June 2015 Location : Clermont-Ferrand (France) View the link.. Read More →

Enterome named as a winner of the Entente Life Sciences Investment Forum 2014

Paris, France – 14 October 2014 Enterome named as a winner of the Entente Life Sciences Investment Forum 2014, an event organized by the ENTENTE.. Read More →

Analysis of human gut microbiome provides new opportunities for liver cirrhosis diagnosis and treatment

Paris, France – 25 July 2014 New publication in Nature by international research team including Enterome scientific founder and Chief Scientific Officer Professor Dusko Ehrlich Read.. Read More →

Enterome to participate on panel at BIO2014 entitled: Microbiome Modulators: Opportunities and Challenges to Creating a New Drug Class

Paris, France – 17 June 2014 Enterome to participate on panel at BIO2014 entitled: Microbiome Modulators: Opportunities and Challenges to Creating a New Drug Class.. Read More →

Enterome quoted in an article published in Nature

NATURE 13 May 2014 Microbiome therapy gains market traction Read the article  .. Read More →

Enterome citée dans les Echos

LES ECHOS – FINANCE MARCHÉS 6 Mai 2014 Les start-up françaises ont réuni près de 500 millions d’euros depuis janvier Accéder à l’article  .. Read More →

Interview de Pierre Belichard à BIOTECHFINANCES

Microbiote : la pépite Enterome lève 10 M€ avec 10 M€ supplémentaires en vue FRANCE 1er Mai 2014– Le tour B se monte à 10M€.. Read More →

Enterome to Chair Panel at Forthcoming Microbiome R&D and Business Collaboration Forum in London, UK

Enterome to Chair Panel at Forthcoming Microbiome R&D and Business Collaboration Forum in London, UK   Paris, France – 24 April 2014 ENTEROME Bioscience SA,.. Read More →

Start of the « FXR-IBD » consortium project

The Marie Curie IAPP project “Industria-Academia exchange to further FXR-based therapeutic intervention and non-invasive diagnosis in Inflammatory Bowel Disease”, in short “FXR-IBD” is starting on.. Read More →

Enterome’s license on “Prognostic of diet impact on obesity-related co-morbidities” patent

Enterome has acquired worldwide rights on “Prognostic of diet impact on obesity-related co-morbidities” patent owned by INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA National Institute.. Read More →

PRESS RELEASES

Enterome further strengthens its leadership team and Board adding clinical development experience

Jai Patel appointed as Chief Medical Officer and Roger J. Garceau elected to the Board New York and Paris, December 9, 2016 Enterome SA a.. Read More →

Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and Bioactive Molecules

New York and Paris, November 16, 2016 Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based.. Read More →

Enterome appoints Christophe Bonny as Chief Scientific Officer

Paris, France and Cambridge, MA, USA – September 19, 2016 Enterome Bioscience SA (“Enterome”), a pioneer in the development of pharmaceuticals and diagnostics based on.. Read More →

Enterome initiates strategic expansion with the opening of US office in Cambridge, MA

Paris, France and Cambridge, MA, USA – May 19, 2016 Enterome Bioscience SA (“Enterome”), a pioneer in the development of pharmaceuticals and diagnostics based on.. Read More →

Enterome raises €14.5 million in Series C financing round Nestlé Health Science invests alongside existing investors

Paris, France and Boston, MA – April 20 2016 ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnosticsbased on the gut microbiome,.. Read More →

Enterome in-licenses novel compounds from Vertex Pharmaceuticals to treat microbiome-related inflammatory bowel diseases

Paris, France and Boston, MA – April 18 2016 ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut.. Read More →

Enterome to participate at the FBR Healthcare Series Conference and the Guggenheim Securities Microbiome Day in New York

Paris, France and Boston, MA – April 13, 2016 ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut.. Read More →

Enterome announces collaboration with Johnson & Johnson Innovation focused on the discovery of novel targets and therapeutics for Crohn’s disease

Paris, France and Boston, MA, USA – January 7, 2016 Enterome Bioscience SA announces that it has entered into a collaborative research agreement with Janssen.. Read More →

Takeda and Enterome enter strategic drug discovery collaboration focused on Microbiome Targets Across Multiple Gastrointestinal Disorders

Osaka, Japan, Paris, France and Boston, MA, USA — January 6, 2016 Takeda Pharmaceutical Company Ltd. and Enterome Bioscience SA today announced they have entered.. Read More →

Georges Gemayel Appointed Non-executive Chairman of Enterome

Paris, France – 29 September 2015 Georges Gemayel Appointed Non-executive Chairman of Enterome ENTEROME Bioscience SA, a pioneer in the development of therapeutic solutions (drugs.. Read More →

Clinica Medtech Intelligence

Paris, France – 6 January 2015 Clinica Medtech Ventures: Enterome Read the Press Release.. Read More →

Enterome enters into a microbiome-based development collaboration with AbbVie in Crohn’s disease

Paris, France – 12 November 2014 Enterome enters into a microbiome-based development collaboration with AbbVie in Crohn’s disease. Collaboration to generate novel diagnostic products to.. Read More →

Enterome and Mayo Clinic Enter Collaboration to Develop and Commercialize Microbiome-based Diagnostic Tools for Nutritional Interventions

Paris, France – 17 June 2014 Enterome and Mayo Clinic Enter Collaboration to Develop and Commercialize Microbiome-based Diagnostic Tools for Nutritional Interventions. Read the Press.. Read More →

Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics’ C. difficile Program

ROCKVILLE, Md. and PARIS, June 10, 2014. Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics’ C. difficile Program — Study to Define Impact.. Read More →

Enterome Raises €10 million in Series B Fund Raising

Enterome Raises €10 million in Series B Fund Raising   Paris, France – 1 May 2014 ENTEROME Bioscience SA, a pioneer in the development of.. Read More →

Enterome appoints Prof. Alessandra Cervino as Head of Discovery

Enterome appoints Prof. Alessandra Cervino as Head of Discovery   Paris, France – 22 April 2014 ENTEROME Bioscience SA, a pioneer in the development of.. Read More →

Launch of Seventure Partners’ new fund

Enterome’s shareholder, SEVENTURE PARTNERS, announced the launch of its new fund. The new management of SEVENTURE PARTNERS drives a group of Industry and Finance Leaders.. Read More →